Healthcare IT

Request for TOC Request for Sample
BUY NOW

Europe AI in Bioinformatics Market – Industry Trends and Forecast to 2029

Healthcare IT | Published Report | Aug 2022 | Europe | 350 Pages | No of Tables: 124 | No of Figures: 39

Report Description

Europe AI in Bioinformatics Market, By Offering (Software, Services and Others), Type (Machine Learning, Deep Learning and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others) - Industry Trends and Forecast to 2029.

Get Exclusive Sample Copy of this Report Here

Europe AI in Bioinformatics Market Analysis and Size

The reduction in the genetic sequencing cost has enhanced the demand of the market. The rising healthcare expenditure for better health services is also attributed to the growth of the market. The major market players are highly focused on various service launches and service approvals during this crucial period. In addition, the growing demand for bioinformatics and increasing public-private sector funding for bioinformatics are also contributing to the rising demand for the market.

Get Exclusive Sample Copy of this Report Here

Get Exclusive Sample Copy of this Report Here

Europe AI in bioinformatics market is growing in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in R&D activity for launching novel services in the market. The increasing advancements in bioinformatics technology are further boosting market growth. However, the high cost of instrumentations and cybersecurity concerns in bioinformatics might hamper the growth of Europe AI in bioinformatics market in the forecast period.

Data Bridge Market Research analyses that the AI in bioinformatics market is expected to reach the value of USD 11,023.14 million by 2029, at a CAGR of 43.0% during the forecast period. “Services" accounts for the largest technology segment in the AI in bioinformatics market due to rapid developments in technological pathways to commercialize the use of handheld AI in bioinformatics. The AI in bioinformatics market report also covers pricing analysis, patent analysis, and technological advancements in depth.         

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Year

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Offering (Software, Services and Others), Type (Machine Learning, Deep Learning and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others)

Countries Covered

U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe in Europe

Market Players Covered

JADBio & Gnosis Data Analysis, Fios Genomics, SOPHiA GENETICS, Biomax Informatics Inc., Ardigen (Parent Company Selvita Group), Source BioScience, QIAGEN, NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific, Inc., Insilico Medicine, Dassault Systèmes, SomaLogic Operating Co., Inc. and among others

Market Definition

Bioinformatics is a sub-discipline that has to do with the analysis of sequences of biological molecules. It usually refers to genes, DNA, RNA, or protein and is particularly useful in comparing genes and other sequences in proteins and other sequences within an organism or between organisms, looking at the evolutionary relationships between organisms, and using the patterns that exist across DNA and protein sequences to figure out what their function is.

Bioinformatics combines computer programming, big data, and molecular biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.

From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, Bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of computer science, statistics, and biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, and others.

In the coming future, important decisions related to bioinformatics, on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify the quality target.

AI in Bioinformatics Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:

  • Growing demand for bioinformatics

As genomics focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research, which involves biologists who learn programming, computer programmers, mathematicians, or database managers to learn the foundations of biology.

  • Reduction in the genetic sequencing cost

The strong demand for decreasing the cost of genomics and biomarker prediction has contributed to the creation of high-throughput genome sequencing, which often goes by the name next-generation sequencing (NGS). Thousands or millions of sequences in a single bioinformatics cycle are generated simultaneously. Dramatic upgrades to industrial NGS technologies have culminated in dramatic cutbacks in DNA sequencing cost-per-base. Thus recently, the main sequencing techniques have become the key subject of research, with sample design optimization taking a secondary function.

  • Increasing public-private sector funding for bioinformatics

In order to improve the workflow for bioinformatics, the federal agencies, the public, and the private agencies are providing funds in order to carry out bioinformatics projects and to scientists for research purposes. It is important to approach possible funders with a clear proposal and strategy of what is to be achieved in terms of bioinformatics capacity building in the institution as well as the intended outputs and outcomes. Many government bodies and private organizations across the globe are increasingly investing in the field of bioinformatics. These investments have largely resulted in data and technological advancements in bioinformatics services, which, in turn, have improved the quality of these services.

  • High cost of instrumentation

The cost of the device plays a major factor in the market. The AI based bioinformatics instrument is highly sophisticated and need high validation and other specification which increase. Genomics instruments are also equipped with advanced features and functionalities and are thus priced at a premium, ranging between ~USD 10–20 million. As pharmaceutical companies and research laboratories require many such systems, their capital expenditure on procuring multiple genomic instruments is very high. In the case of small and medium-sized pharmaceutical companies and research laboratories, it is not feasible for them to make such high investments in multiple genomics instruments. Hence, the high cost of AI based equipment is expected to restrain the market growth.

  • Strategic initiatives of key players

The dramatic rise in the quality of research coupled with increasing research opportunities is because of various strategic initiatives taken by key market players. They are taking initiatives such as product launches, collaborations, mergers, acquisitions, and many more over the years and are expected to lead and create more opportunities in the market.

By successfully working with new technology firms to ensure continued growth, creativity, and viability in the industry, healthcare product suppliers have a huge opportunity. Health enterprises that implement technology-enabled technologies will explore new modes of goods for patient care, streamline processes and engage patients more.

Companies discover and develop advanced bioinformatics products, and these companies are launching new initiatives and collaborating with other key players to deliver more reliable results and services.

  • Advancement in bioinformatics technology

The dimensions and cost of bioinformatics platforms and instruments are decreasing, allowing easier uptake by public health laboratories. Although currently, AI based bioinformatics requires highly specialized equipment and substantially skilled staff to analyze the data, it is unlikely that the bioinformatics revolution has finished. With rising technology up-gradation of instruments and techniques is also needed, moreover, the bioinformatics market has a vast potential to upgrade in various applications, and there are high chances of the advancement of bioinformatics techniques in the forecasted period.

  • Lack of skilled professionals to perform AI based bioinformatics technology

One of biology's most rapidly developing fields of study is bioinformatics, which involves the development and use of computational tools for the collection, archiving, organization, analysis, and visualization of biological data. The advancement of technology has made it possible to reach the level of next-generation analysis from conventional data analysis methods. The advancement of the technology of bioinformatics requires various skill sets for its handling. As the bioinformatics platforms are highly automated and costly machines, the improper handling of such machines can damage their parts which can hamper achieving analysis and visualization of biological data. Thereby, it will proportionally hamper the result of data processing. The dearth of skilled professionals having adequate skills and knowledge to perform next-generation sequencing, therefore, hampers the growth of the market.

Post COVID-19 Impact on AI in Bioinformatics Market

During the pandemic, the North bioinformatics sector is one that focused on using the combination of biology and information technology. At the heart of the industry is biological data, which is analyzed and transformed using IT techniques. Bioinformatics has always had huge potential when it comes to providing essential support to many areas of scientific research. The tools that bioinformatics can provide allow scientists to get to grips with larger data sets to mine and analyses them to discover crucial information that could lead to key discoveries. Genetics and genomes have been the primary focus of bioinformatics in recent years, including comparative genomics, DNA microarrays, and functional genomics.

The growth of the AI in bioinformatics market is increasing with the growing demand for analysis tools in drug discovery and development and the integration of AI in various fields to interpret the data more conveniently. Hence, the market is expected to grow significantly in the forecast period, whereas the cost and the complexity of AI integration may hamper the market growth. The intervention of COVID-19 has increased the R&D activities, which in turn positively add to the market growth.

Recent Developments

  • In June 2022, SOPHiA GENETICS, a leader in data-driven medicine, announced from the ESHG Conference in Vienna that it has achieved CE-IVD certification for the analytical functionality supported by its cloud-based SOPHiA DDM™ Platform, an accessory to diagnostic applications. With this certification, the SOPHiA DDM™ Platform is now IVD-ready to support all applications and modules designed for diagnostic purposes in the European Union and other markets recognizing this certification. This has helped company to increase their Europe presence in the market.
  • In December 2021, JADBio and BioLizard announced their partnership. BioLizard is agile bioinformatics and AI/ML company in Europe servicing clients in the life sciences, biotechnology, and pharmaceutical industries. JADBio is a robust Automated Machine Learning platform that allows intuitive, timely, and interactive creation of ML predictive models on BioMedical and Multi-omics data while allowing for knowledge (biomarker signature) discovery through its vast range of reporting and analysis. This has helped the company to expand its products and services portfolio in the market.

Europe AI in Bioinformatics Market Scope

Europe AI in bioinformatics market is segmented on the basis of offering, type, products and services, application, and sector. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Offering

  • Services
  •  Software
  •  Others

On the basis of offering, the Europe AI in bioinformatics market is segmented into services, software, and others.

Type

  • Machine Learning
  • Deep Learning
  • Others

On the basis of type, the Europe AI in bioinformatics market has been segmented into machine learning, deep learning, and others.

Products and Services

  • Bioinformatics Services
  • Bioinformatics Platforms
  • Knowledge Management Tools

On the basis of products and services, the Europe AI in bioinformatics market has been segmented into bioinformatics services, bioinformatics platforms, and knowledge management tools.

Application

  • Genomics
  • Chemoinformatics & Drug Design
  • Proteomics
  • DNA Sequencing
  • System Biology
  • Transcriptomics
  • Text Mining
  • Microarrays
  • Metabolomics
  • Others

On the basis of application, the Europe AI in bioinformatics market has been segmented into below genomics, chemoinformatics & drug design, proteomics, DNA sequencing, system biology, transcriptomics, text mining, microarrays, metabolomics and others.

Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Others

Get Exclusive Sample Copy of this Report Here

On the basis of sector, the Asia-Pacific AI in bioinformatics market has been segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and others.

AI in Bioinformatics Market Regional Analysis/Insights

The AI in bioinformatics market is analyzed, and market size insights and trends are provided by country, offering, type, products and services, application, and the sector as referenced above.

The countries covered in the Europe AI in bioinformatics market report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey and Rest of Europe. U.K. is expected to dominate the Europe AI in bioinformatics market due to growing start-ups focusing on AI technology in bioinformatics and the rising demand for bioinformatics and its high application in research and development.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing a forecast analysis of the country data.   

Competitive Landscape and AI in Bioinformatics Market Share Analysis

The AI in bioinformatics market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus on the AI in bioinformatics market.

Some of the major players operating in the AI in bioinformatics market are JADBio & Gnosis Data Analysis, Fios Genomics, SOPHiA GENETICS, Biomax Informatics Inc., Ardigen (Parent Company Selvita Group), Source BioScience, QIAGEN, NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific, Inc., Insilico Medicine, Dassault Systèmes, SomaLogic Operating Co., Inc. among others.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE AI IN BIOINFORMATICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 OFFERING LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET SECTOR COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST

5.1.2 GROWING DEMAND FOR BIOINFORMATICS

5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS

5.2 RESTRAINTS

5.2.1 HIGH COST OF INSTRUMENTATION

5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS

5.3 OPPORTUNITIES

5.3.1 RISE IN HEALTHCARE EXPENDITURE

5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS

5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY

5.4 CHALLENGES

5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY

5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB

6 EUROPE AI IN BIOINFORMATICS MARKET, BY OFFERING

6.1 OVERVIEW

6.2 SERVICES

6.3 SOFTWARE

6.4 OTHERS

7 EUROPE AI IN BIOINFORMATICS MARKET, BY TYPE

7.1 OVERVIEW

7.2 MACHINE LEARNING

7.3 DEEP LEARNING

7.4 OTHERS

8 EUROPE AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES

8.1 OVERVIEW

8.2 BIOINFORMATICS SERVICES

8.2.1 DATA ANALYSIS

8.2.2 SEQUENCING SERVICES

8.2.3 DATABASE MANAGEMENT

8.2.4 OTHERS

8.3 BIOINFORMATICS PLATFORMS

8.3.1 SEQUENCE ANALYSIS PLATFORMS

8.3.2 SEQUENCE ALIGNMENT PLATFORMS

8.3.3 STRUCTURAL ANALYSIS PLATFORMS

8.3.4 SEQUENCE MANIPULATION PLATFORMS

8.3.5 OTHERS

8.4 KNOWLEDGE MANAGEMENT TOOLS

8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS

8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS

9 EUROPE AI IN BIOINFORMATICS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 GENOMICS

9.3 CHEMOINFORMATICS & DRUG DESIGN

9.4 PROTEOMICS

9.5 DNA SEQUENCING

9.6 SYSTEM BIOLOGY

9.7 TRANSCRIPTOMICS

9.8 TEXT MINING

9.9 MICROARRAYS

9.1 METABOLOMICS

9.11 OTHERS

10 EUROPE AI IN BIOINFORMATICS MARKET, BY SECTOR

10.1 OVERVIEW

10.2 MEDICAL BIOTECHNOLOGY

10.3 ANIMAL BIOTECHNOLOGY

10.4 PLANT BIOTECHNOLOGY

10.5 ENVIRONMENTAL BIOTECHNOLOGY

10.6 FORENSIC BIOTECHNOLOGY

10.7 OTHERS

11 EUROPE AI IN BIOINFORMATICS MARKET, BY REGION

11.1 EUROPE

11.1.1 U.K.

11.1.2 FRANCE

11.1.3 GERMANY

11.1.4 SPAIN

11.1.5 ITALY

11.1.6 RUSSIA

11.1.7 NETHERLANDS

11.1.8 SWITZERLAND

11.1.9 TURKEY

11.1.10 BELGIUM

11.1.11 REST OF EUROPE

12 EUROPE AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 ILLUMINA, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 DASSAULT SYSTEMES

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.3 EUROFINS SCIENTIFIC

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 THERMO FISHER SCIENTIFIC INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 QIAGEN

14.5.1 COMPANY SNAPSHOT

14.5.2 COMPANY SHARE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENTS

14.6 SOPHIA GENETICS

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 ARDIGEN

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 BIOMAX INFORMATICS AG

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 CELBRIDGESCIENCE.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 DNASTAR

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 ELUCIDATA

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 FIOS GENOMICS

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 INDX. AI.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.14 INSILICO MEDICINE

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 JADBIO & GNOSIS DATA ANALYSIS

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.16 NEOGENOMICS LABORATORIES

14.16.1 COMPANY SNAPSHOT

14.16.2 REVENUE ANALYSIS

14.16.3 PRODUCT PORTFOLIO

14.16.4 RECENT DEVELOPMENTS

14.17 PAIGE AI, INC.

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENTS

14.18 SOMALOGIC OPERATING CO., INC.

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENTS

14.19 SOURCE BIOSCIENCE.

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 STRAND LIFE SCIENCES

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 BIOINFORMATICS COST PER SAMPLE

TABLE 2 EUROPE AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 3 EUROPE SERVICES IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 EUROPE SOFTWARE IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 EUROPE OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 EUROPE AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 EUROPE MACHINE LEARNING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 EUROPE DEEP LEARNING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 EUROPE OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 EUROPE AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 11 EUROPE BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 EUROPE BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 13 EUROPE BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 EUROPE BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 15 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 17 EUROPE AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE GENOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE CHEMOINFORMATICS & DRUG DESIGN IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 EUROPE PROTEOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 EUROPE DNA SEQUENCING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 EUROPE SYSTEM BIOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 EUROPE TRANSCRIPTOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 EUROPE TEXT MINING IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 EUROPE MICROARRAYS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 EUROPE METABOLOMICS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 EUROPE OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 EUROPE AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 29 EUROPE MEDICAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 EUROPE ANIMAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 EUROPE PLANT BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 EUROPE ENVIRONMENTAL BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 EUROPE FORENSIC BIOTECHNOLOGY IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 EUROPE OTHERS IN AI IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 EUROPE AI IN BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 36 EUROPE AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 37 EUROPE AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 38 EUROPE AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 39 EUROPE BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 40 EUROPE BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 41 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 42 EUROPE AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 43 EUROPE AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 44 U.K. AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 45 U.K. AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 46 U.K. AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 47 U.K. BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 48 U.K. BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 49 U.K. KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 50 U.K. AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 51 U.K. AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 52 FRANCE AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 53 FRANCE AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 FRANCE AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 55 FRANCE BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 56 FRANCE BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 57 FRANCE KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 58 FRANCE AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 59 FRANCE AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 60 GERMANY AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 61 GERMANY AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 62 GERMANY AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 63 GERMANY BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 64 GERMANY BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 65 GERMANY KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 66 GERMANY AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 GERMANY AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 68 SPAIN AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 69 SPAIN AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 70 SPAIN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 71 SPAIN BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 72 SPAIN BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 73 SPAIN KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 74 SPAIN AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 75 SPAIN AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 76 ITALY AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 77 ITALY AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 ITALY AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 79 ITALY BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 80 ITALY BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 81 ITALY KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 82 ITALY AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 83 ITALY AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 84 RUSSIA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 85 RUSSIA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 86 RUSSIA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 87 RUSSIA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 88 RUSSIA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 89 RUSSIA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 90 RUSSIA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 91 RUSSIA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 92 NETHERLANDS AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 93 NETHERLANDS AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 94 NETHERLANDS AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 95 NETHERLANDS BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 96 NETHERLANDS BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 97 NETHERLANDS KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 98 NETHERLANDS AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 99 NETHERLANDS AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 100 SWITZERLAND AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 101 SWITZERLAND AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 SWITZERLAND AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 103 SWITZERLAND BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 104 SWITZERLAND BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 105 SWITZERLAND KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 106 SWITZERLAND AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 SWITZERLAND AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 108 TURKEY AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 109 TURKEY AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 110 TURKEY AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 111 TURKEY BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 112 TURKEY BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 113 TURKEY KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 114 TURKEY AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 115 TURKEY AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 116 BELGIUM AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

TABLE 117 BELGIUM AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 118 BELGIUM AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 119 BELGIUM BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 120 BELGIUM BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 121 BELGIUM KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)

TABLE 122 BELGIUM AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 123 BELGIUM AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 124 REST OF EUROPE AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 EUROPE AI IN BIOINFORMATICSMARKET: SEGMENTATION

FIGURE 2 EUROPE AI IN BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE AI IN BIOINFORMATICS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE AI IN BIOINFORMATICS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE AI IN BIOINFORMATICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE AI IN BIOINFORMATICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE AI IN BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE AI IN BIOINFORMATICS MARKET: MARKET SECTOR COVERAGE GRID

FIGURE 9 EUROPE AI IN BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE AI IN BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 11 THE REDUCTION IN THE GENETIC SEQUENCING COST AND GROWING DEMAND FOR BIOINFORMATICS ARE EXPECTED TO DRIVE THE EUROPE AI IN BIOINFORMATICS MARKET IN THE FORECAST PERIOD

FIGURE 12 SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE AI IN BIOINFORMATICS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE AI IN BIOINFORMATICS MARKET

FIGURE 14 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING, 2021

FIGURE 15 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING, 2022-2029 (USD MILLION)

FIGURE 16 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING, CAGR (2022-2029)

FIGURE 17 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING, LIFELINE CURVE

FIGURE 18 EUROPE AI IN BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 19 EUROPE AI IN BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 20 EUROPE AI IN BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 21 EUROPE AI IN BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 EUROPE AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2021

FIGURE 23 EUROPE AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2022-2029 (USD MILLION)

FIGURE 24 EUROPE AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, CAGR (2022-2029)

FIGURE 25 EUROPE AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE

FIGURE 26 EUROPE AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 27 EUROPE AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 28 EUROPE AI IN BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 29 EUROPE AI IN BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 EUROPE AI IN BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 31 EUROPE AI IN BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 32 EUROPE AI IN BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 33 EUROPE AI IN BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 34 EUROPE AI IN BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 35 EUROPE AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 36 EUROPE AI IN BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 37 EUROPE AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 38 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING (2022-2029)

FIGURE 39 EUROPE AI IN BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

View Infographics

FIGURE 1 EUROPE AI IN BIOINFORMATICSMARKET: SEGMENTATION

FIGURE 2 EUROPE AI IN BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE AI IN BIOINFORMATICS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE AI IN BIOINFORMATICS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE AI IN BIOINFORMATICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE AI IN BIOINFORMATICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE AI IN BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE AI IN BIOINFORMATICS MARKET: MARKET SECTOR COVERAGE GRID

FIGURE 9 EUROPE AI IN BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE AI IN BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 11 THE REDUCTION IN THE GENETIC SEQUENCING COST AND GROWING DEMAND FOR BIOINFORMATICS ARE EXPECTED TO DRIVE THE EUROPE AI IN BIOINFORMATICS MARKET IN THE FORECAST PERIOD

FIGURE 12 SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE AI IN BIOINFORMATICS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE AI IN BIOINFORMATICS MARKET

FIGURE 14 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING, 2021

FIGURE 15 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING, 2022-2029 (USD MILLION)

FIGURE 16 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING, CAGR (2022-2029)

FIGURE 17 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING, LIFELINE CURVE

FIGURE 18 EUROPE AI IN BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 19 EUROPE AI IN BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 20 EUROPE AI IN BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 21 EUROPE AI IN BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 EUROPE AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2021

FIGURE 23 EUROPE AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2022-2029 (USD MILLION)

FIGURE 24 EUROPE AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, CAGR (2022-2029)

FIGURE 25 EUROPE AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE

FIGURE 26 EUROPE AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 27 EUROPE AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 28 EUROPE AI IN BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 29 EUROPE AI IN BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 EUROPE AI IN BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 31 EUROPE AI IN BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 32 EUROPE AI IN BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 33 EUROPE AI IN BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 34 EUROPE AI IN BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 35 EUROPE AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 36 EUROPE AI IN BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 37 EUROPE AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 38 EUROPE AI IN BIOINFORMATICS MARKET: BY OFFERING (2022-2029)

FIGURE 39 EUROPE AI IN BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19